Rule 144 filing shows 126-share stock sale

ISRG security holder Curet McAdams filed a Rule 144 notice to sell 126 shares of common stock through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $65,522.52.

Rhea-AI Filing Summary

ISRG security holder Curet McAdams filed a Rule 144 notice to sell 126 shares of common stock through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $65,522.52. The shares were acquired on 01/29/2026 via a stock option exercise paid in cash.

The notice states 354,496,073 shares of common stock outstanding and an approximate sale date of 01/29/2026. Over the prior three months, Curet McAdams sold additional common shares in several transactions, each with disclosed share amounts and gross proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ISRG Rule 144 filing by Curet McAdams disclose?

The Rule 144 filing discloses a planned sale of 126 ISRG common shares. These shares were acquired via a cash stock option exercise on 01/29/2026 and are to be sold on NASDAQ through Morgan Stanley Smith Barney, with an aggregate market value of $65,522.52.

How many ISRG shares are planned to be sold under this Rule 144 notice?

The notice covers a planned sale of 126 ISRG common shares. The filing lists an aggregate market value of $65,522.52 for these shares, to be sold on or around 01/29/2026 on NASDAQ through Morgan Stanley Smith Barney Executive Financial Services.

How were the ISRG shares in this Rule 144 filing acquired?

The 126 ISRG common shares were acquired via a stock option exercise on 01/29/2026. The filing states the transaction was a cash payment to the issuer, indicating the holder exercised options and immediately prepared to sell the resulting shares under Rule 144.

What recent ISRG stock sales by Curet McAdams are disclosed?

The filing lists several ISRG common stock sales over the past three months. Transactions occurred on 11/10/2025, 12/01/2025, 12/10/2025, and 01/27/2026, each showing specific share amounts sold and corresponding gross proceeds, including a 230-share sale with $122,500.30 in gross proceeds.

How many ISRG shares are reported outstanding in this Rule 144 document?

The Rule 144 document reports 354,496,073 ISRG common shares outstanding. This figure is provided as context alongside the planned 126-share sale, helping readers understand the scale of the transaction relative to the issuer’s total common stock base.

Which broker and exchange are involved in this ISRG Rule 144 sale?

The planned Rule 144 sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing specifies that the 126 ISRG common shares are expected to be sold on the NASDAQ market, with an approximate sale date of 01/29/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/29/2026 - 04:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001632901
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	INTUITIVE SURGICAL, INC.
SEC File Number	000-30713
Address of Issuer	1020 KIFER ROAD SUNNYVALE CALIFORNIA 94086
Phone	(408) 523-2100
Name of Person for Whose Account the Securities are To Be Sold	MYRIAM CURET MCADAMS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	126	65522.52	354496073	01/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/29/2026	Stock Option Exercise	ISSUER			126	01/29/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	12/10/2025	104	58229.60
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	12/01/2025	125	71123.75
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	11/10/2025	105	58800.00
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	01/27/2026	230	122500.30

144: Remarks and Signature

Remarks
Date of Notice	01/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Myriam Curet McAdams
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)